WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced the U.S. and international launch of the WallFlex Biliary Transhepatic Stent System. This third-generation stent platform is now available with a percutaneous delivery system designed for use by interventional radiologists in the palliative treatment of biliary strictures produced by malignant tumors.
The company indicated that WallFlex Biliary Transhepatic Fully Covered Stent System is also available for the treatment of benign biliary strictures in CE marked countries.
The WallFlex Biliary Transhepatic Stent is available in fully covered, partially covered and uncovered versions in multiple sizes to accommodate different anatomical and clinical requirements. The covered stents have a silicone polymer Permalume coating designed to reduce the potential for tumor/tissue ingrowth, and an integrated retrieval loop for endoscopic removal or repositioning during the initial procedure in patients that may have an ERCP performed.
Copyright RTT News/dpa-AFX
© 2012 AFX News
